Clopidogrel Camphorsulfonate is a prodrug formulation of the antiplatelet agent clopidogrel, a member of the thienopyridine class designed to prevent thrombotic events such as heart attack and stroke.… Read more
Clopidogrel Camphorsulfonate is a prodrug formulation of the antiplatelet agent clopidogrel, a member of the thienopyridine class designed to prevent thrombotic events such as heart attack and stroke. By irreversibly inhibiting the P2Y12 ADP receptor on platelets, this compound plays a critical role in reducing platelet aggregation in patients with acute coronary syndrome or peripheral artery disease. Analytical laboratories require high-quality reference standards of Clopidogrel Camphorsulfonate, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds, to support rigorous quality control and method validation. These critical materials enable precise impurity profiling and accurate quantification during stability testing and routine drug analysis. By utilizing these specialized compounds, researchers ensure compliance with regulatory standards and maintain the highest levels of accuracy in pharmaceutical product development and manufacturing assessments.